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Ribonucleoproteins (RNPs) mediate key cellular functions such as gene expression and its regula-
tion. Whereas most RNP enzymes are stable in composition and harbor preformed active sites, the
spliceosome, which removes noncoding introns from precursor messenger RNAs (pre-mRNAs),
follows fundamentally different strategies. In order to provide both accuracy to the recognition
of reactive splice sites in the pre-mRNA and flexibility to the choice of splice sites during alterna-
tive splicing, the spliceosome exhibits exceptional compositional and structural dynamics that
are exploited during substrate-dependent complex assembly, catalytic activation, and active site
remodeling.mRNA translation through the combined actions of its small
and large RNP subunits. The ribosome further cooperates with
the signal recognition particle (SRP) RNP to translocate some
newly synthesized proteins into the endoplasmic reticulum.
Protein biosynthesis can also be regulated by microRNPs con-
taining small noncoding RNAs, as was discovered relatively
recently (Figure 1). microRNPs typically recognize 30 untrans-
lated regions of target mRNAs and, depending on the degree
of base-pairing complementarity between their guide RNAs
and the target mRNA, induce transient suppression of translation
or degradation of their target mRNAs (see Review by R.W. Car-
thew and E.J. Sontheimer on page 642 and Review by O. Voinnet
on page 669 of this issue).
RNA-protein complexes are also involved in the biogenesis of
RNAs, including the RNA components of RNPs (Figure 1). For
example, box C/D and box H/ACA small nucleolar RNPs
(snoRNPs) methylate 20-hydroxyl groups and convert uridines
into pseudouridines, respectively, in ribosomal RNAs. A related
group of RNPs, the small Cajal body RNPs (scaRNPs), intro-
duces similar modifications in snRNAs. The maturation of trans-
fer-RNAs (tRNAs) essential to protein translation also requires
the actions of the RNP RNase P, which generates the mature
tRNA 50 end. Indeed, RNPs play a broad role in cellular
processes as even the maintenance of genome stability and
regulation of chromatin states require the action of RNA-protein
complexes such as telomerase and the RNA-induced transcrip-
tional silencing (RITS) complex (Figure 1).
Job Sharing and Cooperation between RNAs
and Proteins
RNPs are involved in a large spectrum of molecular activities.
Whereas assemblies such as the signal recognition particle or
the U7 snRNP serve as adaptors or transport devices, otherAt the Interface of RNA and Protein Worlds
RNAs and proteins cooperate extensively in ribonucleoproteins
(RNPs) to bring about the biological functions of these molecular
machines. Despite their vastly different chemical properties,
these two classes of macromolecules exhibit overlapping
functional repertoires. For example, both can act as biological
catalysts and both can function as versatile binding platforms.
RNA-protein collaborations form the basis of numerous enzy-
matic machineries that mediate key cellular functions.
RNPs are particularly prevalent in the processes of gene
expression and its regulation. Consider for example the life cycle
of a typical eukaryotic mRNA. The mRNA is synthesized as a
precursor (pre-mRNA) during transcription in the nucleus. There,
it undergoes a series of processing steps before being trans-
ported to the cytoplasm where it serves as a template for protein
biosynthesis and where it is eventually degraded (Figure 1). An
mRNA invariably exists as an RNP whose protein inventory
changes during each phase of its existence (see SnapShot by
M. Bergkessel, G.M. Wilmes, and C. Guthrie on page 794 of this
issue). For example, different heterogeneous nuclear RNP
(hnRNP) proteins associate with the pre-mRNA during transcrip-
tion. Some of these proteins are then removed and others are
added as the RNP is remodeled during mRNA processing, nuclear
export, and translation. The particular repertoire of proteins
present at each stage of the mRNA life cycle and their locations
on a pre-mRNA or mRNA determine the fate of the RNA molecule.
RNPs direct many of the cellular processes involving pre-
mRNAs or mRNAs (Figure 1). Uridine-rich (U-rich) small nuclear
RNPs (snRNPs) form the major building blocks of the spliceo-
some, the large RNP that carries out pre-mRNA splicing,
whereas the specialized U7 snRNP directs the 30-end process-
ing of intronless histone pre-mRNAs. Protein biosynthesis is
mediated by another large RNP, the ribosome, which directsCell 136, 701–718, February 20, 2009 ª2009 Elsevier Inc. 701
Figure 1. RNPs in Gene Expression and Its Regulation
RNPs play extensive roles in gene expression and its regulation. Here, the major activities of RNPs during gene expression in a eukaryotic cell are depicted.
Following transcription by RNA polymerases II (RNA Pol II), pre-mRNAs are bound by diverse proteins, such as hnRNP and SR (serine-arginine-rich) proteins.
Pre-mRNAs, containing exons (red) and introns (pink), are subjected to processing by a range of RNPs that include uridine-rich (U-rich) small nuclear RNPs
(U snRNPs) that make up the spliceosome. Certain RNAs such as pre-transfer RNAs and mRNA transcripts encoding histones also undergo processing by
specific RNPs (RNase P and U7 snRNP, respectively). Small nucleolar RNPs (snoRNPs) and small Cajal body RNPs (scaRNPs) mediate maturation of RNA
components of RNPs such as ribosomal RNAs (transcribed by RNA polymerase I, RNA Pol I) and snRNAs, respectively. Small RNAs can form microRNPs
that function to regulate translation. In certain organisms, RNA-induced transcriptional silencing (RITS) complexes, which contain small-interfering RNAs,
mediate heterochromatin formation and maintenance. Telomerase, a box H/ACA snoRNP, replenishes the terminal telomeric repeats of chromosomes to
maintain genomic stability. In the cytoplasm, the ribosome is the key RNP that directs the translation of mRNA into protein. It also functions with the signal recog-
nition particle (SRP) RNP to direct protein translocation into the endoplasmic reticulum (ER). tRNAs also form complexes in the cytoplasm with aminoacyl-tRNA
(aa-tRNA) synthetases, which charge tRNAs with the corresponding amino acid, and with translation elongation factor eEF1A.702 Cell 136, 701–718, February 20, 2009 ª2009 Elsevier Inc.and as guides to identify substrate molecules by Watson/Crick
base pairing. It also includes microRNPs in which guide RNAs
mediate target selection and Argonaute proteins provide the
enzymatic target-slicing activity.
Many RNP machines have acquired larger numbers of
proteins during the course of evolution, as illustrated by RNase
P enzymes or the ribosome. It seems that functions encoded
by RNAs alone in primordial systems have been transferred to
proteins during evolution. These functions include promoting
RNA folding and stability, supporting substrate binding,
increasing the range of substrates, enhancing product release,
and substituting for metal ions that are required for catalysis or
for RNA folding (Hoogstraten and Sumita, 2007). Through these
acquired functions, proteins support catalytic functions even incomplexes such as the sno/scaRNPs, the spliceosome, and the
ribosome act as enzymes (Figure 1). As RNAs and proteins can in
principle functionally substitute for each other (even in their cata-
lytic activity), RNPs span a compositional continuum (Hoog-
straten and Sumita, 2007). At one end of this continuum are
true ribozymes in which RNA is the catalytic entity. These include
self-splicing group II introns, which are found in coding and non-
coding RNAs in all kingdoms of life. Although these ribozymes
function within RNPs in vivo, the proteins in these complexes
play only supporting roles. At the other end of the continuum
are RNPs in which proteins carry out the catalytic function with
RNA playing solely a scaffolding or templating role. This group
includes the sno/scaRNPs, in which the sno/scaRNAs serve
both as scaffolds to assemble the catalytic protein subunits
RNPs where the RNA originally appeared to exclusively mediate
chemical catalysis.
This interdependence of RNA and protein for catalytic
function is particularly evident in the most elaborate and fasci-
nating of extant RNP machines: the ribosome and the spliceo-
some. Both of these assemblies are composed of several
RNAs and numerous proteins that constitute RNP enzymes
in which neither proteins nor RNAs can function without one
another. Some similarities between these two systems have
been noted in the past (reviewed in Konarska and Query,
2005). However, the fundamentally different nature of the
processes mediated by these machines also calls for different
design principles.
Stable versus Dynamic RNP Machines
In many respects, the ribosome is representative of the vast
majority of RNPs, which are compositionally stable and harbor
preformed active sites. The concept of the ribosome as a molec-
ular machine becomes most obvious in the elongation phase of
protein biosynthesis. During elongation, amino acids are added
to a growing peptide chain in a repeating polymerization process
reminiscent of a robotic assembly line. It is also during elongation
that the ribosome carries out its primary functions: the decoding
of mRNA codons in the decoding center of the small subunit and
the formation of new peptide bonds in the peptidyl transferase
center of the large subunit (see Review by H.S. Zaher and R.
Green on page 746 of this issue). The ribosome undergoes
a number of local and global conformational transitions during
peptide chain elongation (Korostelev et al., 2008; Steitz, 2008).
For example, correct tRNA-mRNA pairing is verified by coupling
of a conformational change in the 16S rRNA to new favorable
interactions with the minor groove of a tRNA-mRNA mini-helix
(Ogle et al., 2001). This conformational rearrangement is
accompanied by a global transition of the small subunit from
an open to a closed state. The allosteric cascade is trans-
mitted to the GTPase-associated region on the large subunit,
which stimulates GTP hydrolysis by elongation factor 1A
(eEF1A; EF-Tu in bacteria). GTP hydrolysis triggers the release
of the aminoacyl-tRNA for accommodation within the peptidyl
transferase center. After peptide bond formation, the ribosome
must translocate the message with the associated tRNAs by
one codon. This translocation is driven by eEF2 (EF-G in
bacteria) GTP hydrolysis (Rodnina et al., 1997) and involves
a ratcheting motion of the small subunit with respect to the
large subunit (Frank and Agrawal, 2000).
Notably, except for the repetitive coming and going of elon-
gation factors, the composition of the ribosome remains stable
during elongation. Furthermore, the decoding center and the
peptidyl transferase center are fully preformed in the small
and large subunits, respectively (Steitz, 2008). Structural
(Ogle et al., 2001; Selmer et al., 2006; Simonovic and Steitz,
2008) and kinetic studies (Wohlgemuth et al., 2006) revealed
that the ribosomal subunits function identically either in isola-
tion or within the framework of the entire ribosome. Elongation
factors act to increase the fidelity and directionality of the
translation process but do not seem to be essential for pep-
tidyl transfer or decoding per se. Evidently, subunits with
relatively stable compositions and preformed active sites arewell-suited to support the highly processive polymerase
activity of the ribosome.
The vectorial process of pre-mRNA splicing facilitated by the
spliceosome calls for different design principles. One of the
most distinguishing features of the spliceosome is that it forms
stepwise on the pre-mRNA (Burge et al., 1999). The substrate
pre-mRNA plays an integral role in the formation of an active
site immediately after the initial assembly steps of the complex.
The intricate involvement of the substrate in building the active
sites of the spliceosome goes far beyond the substrate-assisted
catalysis recently revealed as a chemical catalytic principle of
the ribosomal peptidyl transferase center (reviewed in Beringer
and Rodnina, 2007). Another unique principle of the spliceosome
is the initial sequestration of active site RNA components into
inactive conformations for release at the appropriate times to
engage in new interactions (catalytic activation). Indeed, the
extensive structural and compositional dynamics of the spliceo-
some, unprecedented among RNP machines, give it the remark-
able plasticity that also renders it particularly susceptible to
regulation. Regulation is frequently implemented by two combi-
natorial control principles. First, functional sites on the pre-
mRNA are recognized several times by different factors to
ensure splicing fidelity, and second, multiple weak binary inter-
actions act synergistically to consolidate or repress splice-site
choices. A final important aspect of the spliceosome is that its
protein components not only play key roles in the formation of
the RNA/RNP structures required for splicing catalysis but are
also intimate parts of the active sites and may even directly
participate in splicing catalysis. This unparalleled degree of
cooperation between RNA and proteins makes the spliceosome
a paradigm for a mixed RNA/protein enzyme (Abelson, 2008). In
the following, we will describe the molecular mechanisms under-
lying the exceptional dynamics of the spliceosome.
The Spliceosome, a Highly Dynamic RNP Machine
Nuclear pre-mRNA splicing entails two SN2-type transesterifica-
tion reactions, relatively simple chemical reactions involving
functional groups from three reactive regions in the pre-mRNA.
First, the phosphodiester bond at the 50 splice site (SS) is at-
tacked by the 20-hydroxyl of an adenosine of the branch point
sequence (BPS) in the intron, which generates a free 50 exon
and an intron lariat-30 exon. Subsequently, the 30-hydroxyl of
the 50 exon attacks the phosphodiester bond at the 30SS, leading
to exon ligation and excision of the lariat intron (Figure 2). The
50SS, BPS, and 30SS of nuclear pre-mRNA introns are defined
by very short consensus elements that, in metazoans, are also
very poorly conserved (Figure 2A). As a consequence, these
introns contain relatively little consistent secondary or tertiary
structural information. Therefore, unlike self-splicing group II
introns that, on their own, can adopt a three-dimensional fold
with an active site in which the reactive groups of the intron are
juxtaposed (Toor et al., 2008), the folding of nuclear pre-mRNA
introns in a manner conducive to splicing is dependent on a multi-
tude of trans-acting factors that comprise the spliceosome.
During splicing, the spliceosome must overcome a number of
challenges. These include the correct recognition and pairing
of the splice sites within a multitude of similar sequences, as
well as the positioning of these splice sites (which may lie tensCell 136, 701–718, February 20, 2009 ª2009 Elsevier Inc. 703
Figure 2. Pre-mRNA Splicing by the Major
Spliceosome
(A) Conserved sequence elements of metazoan
and yeast pre-mRNAs. Here, two exons (blue)
are separated by an intron (gray). The consensus
sequences in metazoans and yeast at the 50 splice
site (SS), branch point sequence (BPS), and 30
splice site (SS) are as indicated, where N is any
nucleotide, R is a purine, and Y is a pyrimidine.
The polypyrimidine tract is a pyrimidine-rich
stretch located between the BPS and 30SS.
(B) Cross-intron assembly and disassembly cycle
of the major spliceosome. The stepwise interaction
of the spliceosomal snRNPs (colored circles), but
not non-snRNP proteins, in the removal of an intron
from a pre-mRNA containing two exons (blue) is de-
picted. Only the spliceosomal complexes that can
be resolved biochemically in mammalian splicing
extracts are shown. Eight evolutionarily conserved
DExD/H-type RNA-dependent ATPases/helicases
act at specific steps of the splicing cycle to catalyze
RNA-RNA rearrangements and RNP remodeling
events. These enzymes include Sub2 (UAP56 in hu-
mans), Prp5, Prp28, Brr2, Prp2, Prp16, Prp22, and
Prp43 (with Brr2 and Prp22 acting at more than one
step in the cycle). The GTPase Snu114 also func-
tions at several steps during the cycle. In yeast,
Prp28 acts at a later stage during spliceosome acti-
vation (the B complex to B* complex transition)
(Staley and Guthrie, 1998). Several of these
proteins, such as Prp5, Prp16, and Prp22, also
carry out proofreading functions at the stages
where they are shown.
(C) Cross-exon splicing complexes form on long
introns during the earliest stage of spliceosome
assembly. An SR protein containing an arginine-
serine-rich (RS) domain and RRM (RNA recogni-
tion motif) is depicted as interacting with an exonic
splicing enhancer (ESE). The U1 (blue) and U2
(green) spliceosomal snRNPs and the two
subunits of the U2 auxilliary factor (U2AF),
U2AF65 and U2AF35, are also shown interacting
with the splice sites flanking the exon.704 Cell 136, 701–718, February 20, 2009 ª2009 Elsevier Inc.otes, the spliceosome must not only catalyze splicing with great
precision but also exhibit a high degree of flexibility that allows
a rapid response to regulatory signals.
Stepwise Assembly of the Splicing Machinery
The U1, U2, U4/U6, and U5 snRNPs are the main building blocks
of the major spliceosome, which is responsible for removing the
vast majority of pre-mRNA introns. Some metazoan species and
plants contain a second, minor spliceosome that is composed of
the compositionally distinct but functionally analogous U11/U12
and U4atac/U6atac snRNPs, with the U5 snRNP shared between
the machineries (reviewed in Patel and Steitz, 2003). Each snRNP
consists of an snRNA (or two in the case of U4/U6) and a variable
number of complex-specific proteins. In addition, the U1, U2, U4,
and U5 snRNPs all contain seven Sm proteins. In contrast to ribo-
somal subunits, none of these particles possess a preformed
active center and several of the snRNPs are substantially remod-
eled in the course of the splicing reaction.
In the consensus view of spliceosome assembly (Figure 2B)
(based on in vitro studies using native gel electrophoresis, affinityof thousands of nucleotides apart) within the atomic distance
that allows the transesterification reactions to proceed. Solu-
tions to these problems come from the large number of subunits
in the spliceosome and the principles by which the various
protein and RNA players are brought together on the substrate
pre-mRNA.
Whereas some exons are constitutively spliced, that is, they
are present in every mRNA produced from a given pre-mRNA,
many are alternatively spliced (especially in higher eukaryotes)
to generate variable forms of mRNA from a single pre-mRNA
species (reviewed in Black, 2003; Blencowe, 2006; Graveley,
2001; Smith and Valcarcel, 2000). Alternative splicing enhances
the complexity of the proteomes of higher organisms. Under-
standing regulated splicing is of prime medical relevance, as
many human genetic diseases are associated with aberrant
pre-mRNA splicing (Nissim-Rafinia and Kerem, 2005; Wang
and Cooper, 2007) (see Review by T.A. Cooper, L. Wan, and
G. Dreyfuss on page 777 of this issue). To accommodate the
highly regulated nature of the splicing process in higher eukary-
Figure 3. Molecular Interactions at the
Branch Site and 30SS within the Spliceoso-
mal E and A Complexes
(Top) In the spliceosomal E complex, the pre-
mRNA (exons, blue; introns, gray) branch site is
bound by SF1/BBP, whereas the polypyrimidine
tract and 30 splice site (SS) are bound by the
U2 auxilliary factor (U2AF) subunits U2AF65 and
U2AF35, respectively. U2AF65 binds both SF1/
BBP and U2AF35.
(Bottom) Upon stable U2 snRNP binding during A
complex formation, SF1/BBP is displaced, allow-
ing the U2-associated protein p14 to contact the
BPS and U2AF65 to interact with SF3b155. The
U2/BPS base-pairing interaction is stabilized by
components of the U2 snRNP and by the argi-
nine-serine-rich (RS) domain of U2AF65. Adapted
in part from Mackereth et al. (2005).are recognized multiple times by RNA or protein to ensure the
precision of the splicing reaction. Second, many functionally
important binary interactions in the spliceosome are often
weak but are enhanced by a combination of multiple interac-
tions. This is a design principle that is crucial for the flexibility
of the spliceosome, in particular during regulated splicing
events. Third, RNP rearrangements during spliceosome
assembly (and later during catalytic activation) generally involve
the handing over of one or more binding partners to new interac-
tion partners. These RNP rearrangements are relatively well
understood for this early stage of the splicing process but are
more poorly characterized for the subsequent steps of spliceo-
some assembly and catalytic activation. It is known that U2AF
dissociates at later stages of splicing and also that the
U2AF35-30SS interaction is replaced by a different set of factors
after the first transesterification reaction (reviewed in Umen and
Guthrie, 1995).
Subsequent to A complex formation, the U4/U6 and U5
snRNPs are recruited as a preassembled U4/U6.U5 tri-snRNP,
forming the B complex (Figure 2B). Although all snRNPs are
present in the B complex, it is still catalytically inactive and
requires major conformational and compositional rearrange-
ments (catalytic activation) in order to become competent to
facilitate the first transesterification step of splicing. During spli-
ceosome activation, U1 and U4 are destabilized or released,
giving rise to the activated spliceosome (the B* complex). The
activated spliceosome then undergoes the first catalytic step
of splicing, generating the C complex. Prior to the second cata-
lytic step, additional rearrangements occur in the spliceosomal
RNP network (Konarska et al., 2006). After the second catalytic
step, the spliceosome dissociates, releasing the mRNA in the
form of an mRNP. It also releases the U2, U5, and U6 snRNPs
to be recycled for additional rounds of splicing.
A number of recent observations, foremost the isolation under
low-salt conditions (50 mM NaCl) of a yeast complex consisting
of all five spliceosomal snRNPs (termed the penta-snRNP; Ste-
vens et al., 2002), have led to the hypothesis that the spliceo-
some can also exist in a more extensively preassembled formselection, and glycerol gradient centrifugation), landmark
assembly intermediates are operationally defined by the sequen-
tial association and release of the spliceosomal snRNPs
(reviewed in Brow, 2002; Will and Lu¨hrmann, 2006). Assembly
begins with the ATP-independent binding of the U1 snRNP
through base-pairing interactions of the 50 end of the U1 snRNA
to the 50SS of the intron. This interaction in higher eukaryotes is
stabilized by members of the serine-arginine-rich (SR) protein
family and proteins of the U1 snRNP. Indeed, most of the func-
tionally important RNA-RNA interactions formed within the spli-
ceosome are weak and generally require the assistance of
proteins to enhance their stability. In addition to the U1-50SS
interaction, the earliest assembly phase of the spliceosome
also involves the binding of the SF1/BBP protein and the U2
auxiliary factor (U2AF) to the BPS and the polypyrimidine tract
just downstream of the BPS, respectively (Figure 3). These
proteins bind cooperatively, with SF1/BBP interacting with the
65 kDa subunit of U2AF (U2AF65) through its C-terminal RNA
recognition motif (RRM). In addition, the 35 kDa subunit of
U2AF, which is tightly bound to U2AF65 in the U2AF hetero-
dimer, binds the AG dinucleotide of the 30SS. Together, these
molecular interactions yield the spliceosomal E complex and
play crucial roles in the initial recognition of the 50SS and 30SS
of an intron.
After the formation of the spliceosomal E complex, the U2
snRNA engages in an ATP-dependent manner in a base-pairing
interaction with the pre-mRNA’s BPS, leading to the formation of
the A complex. This base-pairing interaction is stabilized by het-
eromeric protein complexes of the U2 snRNP, namely SF3a and
SF3b (Gozani et al., 1996), and also by the arginine-serine-rich
domain of the U2AF65 protein (Valcarcel et al., 1996). Associa-
tion of U2 leads to the displacement of SF1/BBP from the BPS
(Figure 3). The latter interaction is replaced (at least in higher
eukaryotes) by association of SF3b14a/p14 with the BPS aden-
osine (Will et al., 2001). Moreover, SF3b155 now interacts with
the C-terminal RNA recognition motif of U2AF65 (Gozani et al.,
1998). These steps illustrate three reoccurring principles of the
splicing process. First, the reactive groups of the pre-mRNACell 136, 701–718, February 20, 2009 ª2009 Elsevier Inc. 705
such that all of the snRNPs could interact concomitantly with the
pre-mRNA. However, all of the major RNA-RNA and RNP remod-
eling events described below, as well as changes in the compo-
sition of the spliceosome, would still be required to generate its
catalytically active RNP structure (Brow, 2002).
Alternative Spliceosome Assembly Pathways
The initial assembly of the spliceosome across an intron appears
to be limited to pre-mRNAs containing single or very short
introns. In the case of long introns (which are the rule rather
than the exception in metazoans), spliceosomal components
first assemble across an exon (so-called exon definition; Berget,
1995), with U1 recognizing the downstream 50SS, U2AF, and U2
snRNP binding the upstream polypyrimidine tract and BPS,
respectively, and SR proteins mediating cross-exon interactions
(Figure 2C). In a subsequent step, these cross-exon interactions
must be replaced by cross-intron interactions, a process that at
present is very poorly understood. The ability of the spliceosome
to initially form a cross-exon or cross-intron complex with a pre-
mRNA substrate illustrates that alternative spliceosome
assembly pathways exist, at least during the earliest stages of
assembly.
Cis-Acting Regulatory Elements in Splice-Site Selection
Which 50SS and 30SS are recognized and subsequently paired by
the spliceosome clearly influences the sequence of the mRNA
that is ultimately produced. Splice site selection in higher eukary-
otes is determined by multiple factors. First, the relative strength
of a given splice site can play an important role in this process,
with sites that have greater affinity for U1 or U2AF, in general,
being more efficiently recognized. However, as most splice site
consensus sequences are relatively degenerate, at least in
higher eukaryotes where alternative splicing is predominant,
splice sites alone are not capable of efficiently directing spliceo-
some assembly. Recognition and selection of splice sites is in
most cases influenced by flanking pre-mRNA regulatory
sequences—so-called intronic and exonic splicing enhancers
or silencers—that can have positive or negative effects on
splice-site usage (Cartegni et al., 2002; Singh and Valcarcel,
2005). These cis-acting elements mediate their effects primarily
by functioning as binding sites for trans-acting regulatory factors
that in turn recruit the snRNP subunits of the splicing machinery
to the adjacent splice site or, in the case of negative regulators,
prevent their association. Exonic splicing enhancers (ESEs) are
often bound by SR proteins whereas exonic splicing silencers
(ESSs) are typically bound by hnRNP proteins. Indeed, these
two classes of proteins often have antagonistic effects on
splice-site usage. The SR protein ASF/SF2 and hnRNP A1 are
a well-characterized example of factors that exhibit antagonistic
effects (Black, 2003; Caceres et al., 1994; Zhu et al., 2001). Ulti-
mately, it is the sum of multiple factors, some exerting positive
effects and others exerting negative effects, that decides
whether a particular site is recognized by the spliceosome for
inclusion of the adjacent exon in the mRNA product.
SR proteins bind both the pre-mRNA and other RS domain-
containing spliceosomal proteins with low affinity and specificity.
Low binding affinity, essential for the dynamic nature of the spli-
ceosome, is a common characteristic not only of regulatory
splicing factors but also of core components of the spliceosome.
Canonical SR proteins are for the most part absent from yeast,706 Cell 136, 701–718, February 20, 2009 ª2009 Elsevier Inc.where alternative splicing events are rare. With the exception
of the SR-like protein Npl3 (Kress et al., 2008), SR proteins do
not appear to function in yeast pre-mRNA splicing. Significantly,
exonic splicing enhancers also appear to be extremely rare in
yeast pre-mRNAs. Furthermore, the yeast 50SS and BPS
consensus sequences are typically defined by perfect comple-
mentarity to regions of the U1 and U2 snRNAs, respectively.
Thus, the degeneration of the consensus elements defining the
50SS, 30SS, and the BPS in metazoans correlates with the addi-
tion of SR proteins to the repertoire of splicing regulatory factors
(reviewed in Izquierdo and Valcarcel, 2006).
Dynamics of the Spliceosomal RNA-RNA
Interaction Network
As is the case for the ribosome, the splicing process is accompa-
nied by profound conformational rearrangements. However, the
dynamic nature of the spliceosome in terms of its compositional
changes and RNP rearrangements is unprecedented among
RNP machines. Instead of the repetitive, cyclical conformational
changes of the ribosome, the spliceosome undergoes a cascade
of major structural rearrangements during the evolution of its
active sites. This cascade is best illustrated by the dramatic
changes in its snRNA-snRNA and pre-mRNA-snRNA interaction
networks (Nilsen, 1998; Staley and Guthrie, 1998). Major players
in spliceosomal RNA-RNA rearrangements (and also RNP
remodeling events) are the spliceosome-associated DExD/H-
type RNA-dependent ATPases/helicases (Staley and Guthrie,
1998).
After the initial base pairing of U1 with the 50SS and U2 with the
BPS of the pre-mRNA, snRNA components of the U4/U6.U5 tri-
snRNP engage in base-pairing interactions with the pre-mRNA.
In these interactions, U5 contacts nucleotides of the 50 and 30
exon, and the 30 end of U6 base pairs with the 50 end of U2 (Nil-
sen, 1998) (Figure 4A). Nucleotides of the U6 snRNA comprise
essential components of the active site but are initially delivered
to the spliceosome in an inactive form where the catalytically
important regions of U6 are base paired with U4. During catalytic
activation, U1 is displaced from the 50SS, U4/U6 base-pairing
interactions are disrupted, and the conserved ACAGAG box of
the U6 snRNA engages intron nucleotides at the 50SS. Addi-
tional, short U2/U6 duplexes are formed (Figure 4A) and U6 is re-
folded, forming an intramolecular stem loop (U6-ISL) that in yeast
is involved in metal binding (Yean et al., 2000). The initial inacti-
vation of U6 and its liberation by conformational rearrangements
are a major principle by which the spliceosome ensures that the
pre-mRNA is not cleaved prematurely.
Changes in base-pairing interactions that make up the two-
dimensional RNA-RNA interaction network are generally well
understood. However, as it is difficult to isolate conformationally
homogenous spliceosome assembly intermediates, several
uncertainties in the current model of RNA rearrangements still
remain. For example, the precise nature of the U2/U6 base-pair-
ing interactions immediately prior to catalysis is unclear and it is
not known in which order the various U2/U6 helices form. In prin-
ciple, the nature and dynamics of the spliceosomal RNA network
are likely evolutionarily conserved from yeast to man with only
minor differences that include the exact nature of the U2/U6
base-pairing interactions (Hilliker and Staley, 2004; Madhani
Figure 4. Spliceosomal RNA Network and
Coordination of Prp28 and Brr2 Activities
by Prp8
(A) The network of RNA interactions in the preca-
talytic (left) and activated spliceosome (right).
During activation of the spliceosome, regions of
U6 and U2 (yellow or red) undergo major rear-
rangements. The 50 end (black ball) of the U6
snRNA base pairs through its highly conserved
ACAGAG motif to the 50 splice site (SS), displac-
ing U1. U4 and U1 are destabilized or dissociate
from the spliceosome at the time of activation
and no longer are part of the spliceosome’s
RNA interaction network. Spliceosomal snRNAs
are depicted with secondary structures observed
in mammals and are not drawn to scale. Only
stem loop I of U5 is shown. Critical base-pairing
interactions are highlighted.
(B) Surface view of the expanded RNase H-like
domain of yeast Prp8 with a 50SS RNA modeled
onto the mitten-like structure (reprinted with
permission from Pena et al., 2008). Colored regions
encompass residues that exhibit genetic interac-
tions to the factors indicated. The numerous
genetic interactions are consistent with a role for
Prp8 in mediating the kinetic competition between
two different spliceosome conformations that
support the two catalytic steps of splicing (Query
and Konarska, 2004). A surface patch (yellow) is
a functional hotspot surrounding a truncated
RNase H-like active center. The surface patch of
a Prp8 peptide that can be crosslinked to the 50
splice site (SS) in a trans-splicing system after
addition of the tri-snRNP and after establishment
of a 50SS-U6 ACAGAG motif contact (Reyes
et al., 1996) is circled (XL). During the same
assembly stage, the active center of Prp28 can
also be crosslinked near the 50SS (Ismaili et al.,
2001), demonstrating its close physical proximity to the Prp8 RNase H domain before spliceosome catalytic activation. PPy—polypyrimidine tract.
(C) Coordination of Prp28 and Brr2 activities by Prp8. A pre-mRNA-snRNA interaction network before catalytic activation (U1 snRNA base paired to the 50SS, U6
snRNA base paired to U4 snRNA) is shown on an outline of the yeast Prp8 RNase H-like domain (residues 1836–2087; Pena et al., 2008) and the yeast Prp8 Jab1/
MPN domain (residues 2147–2391; Pena et al., 2007). A dashed line connects the approximate positions of the C terminus of the RNase H domain and the
N terminus of the Jab1/MPN domain in Prp8. Regions of the Prp8 domains interact with Prp28 (red circle) and Brr2 (green circle) to regulate their function. The
C-terminal Jab1/MPN domain of Prp8 directly contacts Brr2 and stimulates its helicase activity (Maeder et al., 2009).and Guthrie, 1992; Sun and Manley, 1995). At present, informa-
tion about the nature and dynamics of RNA tertiary interactions
in the spliceosome is particularly scarce. Thus, conformational
rearrangements in the RNA interaction network of the spliceo-
some are certainly even more complex than current models
would suggest.
The Spliceosome Is a Protein-Rich Machine
The spliceosome is a particularly protein-rich RNP where
proteins make up more than two-thirds of its mass (in the case
of spliceosomes assembled on short pre-mRNA introns). Thus,
in addition to protein-RNA interactions, protein-protein interac-
tions are expected to be prevalent and to play functionally impor-
tant roles. Human spliceosomes contain 45 distinct snRNP-
associated proteins, which contribute 2.7 MDa of molecular
mass. As a consequence of its complexity, assembly of the spli-
ceosome represents a kinetic challenge that is met, in part, by
prepackaging many spliceosomal proteins in the form of snRNPs
or in stable preformed heteromeric complexes. Human spliceo-somes also contain numerous non-snRNP proteins. Initial mass
spectrometric analyses of a mixed population of affinity-purified
spliceosomal complexes indicated that between 150 (Zhou
et al., 2002) and 300 distinct proteins (Rappsilber et al., 2002)
copurify with spliceosomes. More recently it has been possible
to purify spliceosomes at more defined stages of assembly
and function (Behzadnia et al., 2007; Bessonov et al., 2008;
Deckert et al., 2006; Hartmuth et al., 2002; Jurica et al., 2002;
Makarov et al., 2002, 2004). These studies indicated that the total
number of spliceosome-associated factors is approximately
170, with individual assembly intermediates (e.g., A, B, and C
complexes) each containing generally about 125 proteins or
less (in the case of the A complex) (Figure 5). In addition, they
revealed a remarkable exchange of proteins from one stage to
the next during the splicing process.
Although the majority of proteins identified in spliceosomes
have clear roles in the splicing process per se, the function of
many others is unclear. A number of spliceosome-associated
proteins are likely involved in coupling the splicing machineryCell 136, 701–718, February 20, 2009 ª2009 Elsevier Inc. 707
to other molecular machines in the cell such as those responsible
for transcription, 30-end processing, or quality control of spliced
mRNPs (reviewed in Jurica and Moore, 2003; Maniatis and
Reed, 2002). Many of the non-snRNP proteins identified appear
to be present in substoichiometric amounts in the individual
assembly intermediates. Rather than reflecting simply the partial
loss of some proteins during the purification procedure, the pres-
Figure 5. Compositional Dynamics of
Human A, B, and C Spliceosomal Com-
plexes
The protein composition of the human A complex
(formed on MINX pre-mRNA) (Behzadnia et al.,
2007), the human B complex (a consensus of
complexes formed on MINX and PM5 pre-
mRNA) (Bessonov et al., 2008; Deckert et al.,
2006), and the human C complex (formed on
PM5 pre-mRNA) (Bessonov et al., 2008) as deter-
mined by mass spectrometry. Proteins (human
nomenclature) are grouped according to snRNP
association, function, presence in a stable hetero-
meric complex, or association with a particular
spliceosomal complex, as indicated. The relative
abundance of proteins is indicated by light (sub-
stoichiometric amounts) or dark (stoichiometric
amounts) lettering and is based on the relative
amounts of peptides sequenced or, in some
cases, also by immunoblotting experiments.
Numbers indicate the total number of individual
proteins in a particular group. SR proteins identi-
fied include ASF/SF2, 9G8, SRp20 Tra2-a,
SRp30c, SRp38, SRp40, Srp55, and SRp75.
HnRNP proteins include hnRNPA1, A3, C, G, K,
M, U, and PCBP1. mRNP proteins include ASRBP,
NFAR, NF45, BCLAF-1, YB-1, HuR, LOC124245,
and RNPC2. Some exon junction complex (EJC)
proteins (Acinus and eIF4A3) and factors involved
in step 2 of the splicing reaction (Prp17) are also
observed in B complex preparations, though this
is likely due to the presence of low amounts of
contaminating B* complexes. A small subset of
Prp19 complex proteins are also detected in low
amounts in A complex preparations isolated under
low-salt conditions.
ence of less abundant proteins, in partic-
ular those involved in splicing regulation,
hints at another design principle. These
proteins could represent examples of
a host of loosely associated proteins
whose regulated actions provide flexi-
bility and specificity to spliceosome func-
tion.
Dramatic Changes in the
Spliceosome Protein Inventory
Mass spectrometric analyses of different
assembly intermediates indicate that
there is a dramatic exchange of proteins
during spliceosome assembly and activa-
tion. A comparison of the protein compo-
sitions of human A, B, and C complexes
affinity-purified under identical physiological conditions (Figure 5)
reveals three principles regarding the spliceosome’s composi-
tion during the course of splicing. First, several different groups
of spliceosomal proteins are present in the spliceosome
throughout the splicing cycle, including U2-associated proteins
and members of the SR and hnRNP protein families (which are
present in varying abundance). Second, during the A complex708 Cell 136, 701–718, February 20, 2009 ª2009 Elsevier Inc.
to B complex and B complex to C complex transitions, a large
number of additional spliceosomal proteins are recruited. Third,
numerous spliceosomal proteins are released or destabilized at
each stage during the splicing process. During the A complex to
B complex transition, 25 proteins are recruited as part of the
tri-snRNP complex. However, more than 35 non-snRNP
proteins also associate at this stage. These include compo-
nents of the heteromeric Prp19/CDC5 protein complex
(composed of at least seven subunits and the functional equiv-
alent of the yeast nineteen complex [NTC]; Makarova et al.,
2004) and a group of proteins designated Prp19/CDC5-related
(which either physically interact with the Prp19 or CDC5
proteins in humans or yeast or were present with Prp19 in
the human 35S U5 snRNP) (Ajuh et al., 2000; Chen et al.,
1999, 2002). They also include proteins of the RES (retention
and splicing) complex (Dziembowski et al., 2004) and an addi-
tional group of 15 proteins, 5 of which are abundant in the B
complex but essentially absent from the C complex. During
the conversion of the B complex to the C complex (which
encompasses catalytic activation), most so-called step 2
factors (proteins known to function just prior to or during the
second transesterification reaction) are recruited. In addition,
a large number of proteins designated C complex specific
associate together with several DExD/H-box helicases and
peptidyl-prolyl cis/trans isomerases (PPIases). These helicases
and isomerases may be responsible for RNP conformational
changes at this or later stages of the splicing process. Finally,
most members of the exon junction complex (EJC), which is
deposited upstream of the exon-exon splice junctions of the
mRNA and influences its subsequent metabolism in the cell
(reviewed in Tange et al., 2004), are also recruited at this stage
of transition from the B complex to the C complex.
In addition to these elaborate recruitment events, spliceoso-
mal proteins are released or destabilized during the A complex
to B complex and B complex to C complex transition. Thus,
several non-snRNP proteins of the A complex (designated
‘‘A complex proteins’’; Figure 5) are no longer found in the
B complex. Likewise, all U1- and U4/U6-associated proteins
dissociate or are destabilized during the B complex to C complex
transition, together with most U2-related proteins and several
non-snRNP proteins (designated ‘‘B complex’’; Figure 5). Recent
evidence also indicates that the U2-associated heteromeric
complexes SF3b and SF3a are less stably bound at this stage
(Bessonov et al., 2008), indicating an RNP remodeling event
that may be related to the rearrangement of the spliceosome’s
active site prior to the second transesterification step (Konarska
et al., 2006; Smith et al., 2008). Significantly, a large portion of
those proteins originally present in the A complex are no longer
a part of the catalytically active C complex, attesting to the large
turnover of spliceosomal proteins. Most of what is known about
the dynamics of the spliceosome’s composition is based on
experiments performed in vitro. Thus, the loss of some proteins
may result from the isolation procedure itself. Some of the
changes observed in vitro may also simply reflect binding desta-
bilization rather than bona fide dissociation events. However,
recent data support the idea that many of the compositional
changes observed in vitro also occur in living cells (see discus-
sion of tri-snRNP remodeling).To date, human B* complexes have not been isolated under
physiological conditions. However, mass spectrometric anal-
yses of B versus B* complexes isolated under nonphysiological,
stringent conditions indicate that the loss of U4/U6-associated
proteins occurs during the B to B* transition (Makarova et al.,
2004). In addition, subunits of the Prp19/CDC5 complex and
its related proteins become more stably integrated in the B*
complex, indicating that there are major RNP remodeling events
involving these proteins during activation (Makarov et al., 2002,
2004).
Most of what we know about the dynamics of the spliceosome
composition comes from studies in human cell extracts. Many
known splicing factors are highly conserved between man and
yeast. Based on their numbers, the evolutionarily conserved
core machinery of the spliceosome likely consists of 80
proteins. Due to the limited amount of regulated splicing in yeast,
its splicing machinery is generally expected to be less complex
than that of humans. However, answers to these questions await
proteomic analyses of purified spliceosomal complexes from
yeast. The number of proteins of the splicing machinery that
are required for maintaining the catalytically active RNP network
of the step 1 spliceosome (C complex) consists of about 35–40
proteins (Bessonov et al., 2008), almost all of which have highly
conserved orthologs in yeast. Thus, the inner workings of the
spliceosome also appear to be highly conserved across evolu-
tion.
A Flexible Source of Spliceosomal Proteins
In order to be prepared for the splicing of a wide variety of pre-
mRNA introns and also to react better to changes in the state
of the cell or its environment, the spliceosome appears to contain
many proteins that are loosely associated and are only called
into action or required in certain situations. A prime example is
the regulatory protein RBM5 (RNA-binding motif protein 5), a crit-
ical player in the regulated splicing of the FAS pre-mRNA encod-
ing the apoptotic factor FAS (Bonnal et al., 2008). RBM5
represses the splicing of Fas pre-mRNA by blocking the conver-
sion of a cross-exon complex assembled on the pre-mRNA to
a cross-intron complex. Consistent with its role early in spliceo-
some assembly, RBM5 dissociates from the spliceosome during
the A complex to B complex transition, suggesting that other
A complex proteins released at this stage may also play a role
in regulating splicing. By analogy, it is also highly likely that other
spliceosome-associated proteins, in particular those that are
loosely associated or present in substoichiometric amounts,
are utilized during the splicing of specific introns or under
specific cellular conditions. Indeed, several proteins with appar-
ently redundant functions (such as different SR proteins or
U2AF65 and PUF60) are found in purified spliceosomes.
U2AF65 and PUF60 are homologous proteins, and PUF60 can
substitute for U2AF65 during early recognition of the 30SS (Hast-
ings et al., 2007). However, PUF60 plays a more important role in
the recognition of introns with a weak 30SS (Hastings et al., 2007).
Recent knockdown experiments in flies and mutational analyses
in yeast in which core components of the spliceosome were tar-
geted revealed that depletion or mutation of different factors
resulted in differential effects on global splicing patterns, with
large defects in the splicing of some genes but moderate or little
effect on other genes (Clark et al., 2002; Park et al., 2004; PleissCell 136, 701–718, February 20, 2009 ª2009 Elsevier Inc. 709
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its active sites, and the catalytic steps of splicing all involve major
RNP remodeling events.
Most of these events appear to be evolutionarily conserved.
For example, the general tri-snRNP remodeling events observed
in HeLa cell splicing extracts, including the loss or destabilization
of U4/U6 and tri-snRNP-specific proteins during activation, have
also been observed by mass spectrometric analyses of different
spliceosomal complexes from the fly Drosophila melanogaster
(Herold et al., 2009). In addition, endogenous yeast spliceo-
somes that likely represent a post-catalytic form of the splicing
machinery also lack all U4/U6 proteins and several U5-specific
proteins (Ohi et al., 2002). Finally, there is evidence in yeast
that the LSm 2–7 proteins dissociate at the time of spliceosome
activation (Chan et al., 2003). Remodeling of the tri-snRNP also
appears to occur in vivo. Recent fluorescence resonance energy
transfer studies in human cells indicated that during splicing, the
tri-snRNP dissociates. In particular, these studies showed that
after taking part in splicing, the U5 and U4/U6 snRNPs reassem-
ble in Cajal bodies, away from the sites where splicing takes
place (Stanek et al., 2008).
Mediators of Spliceosome Dynamics
The dynamic remodeling of RNA-RNA, RNA-protein, and
protein-protein interactions during spliceosome assembly re-
quires multiple driving forces and tight control of molecular
switches. Enzymes such as DExD/H-type RNA-dependent
ATPases/helicases and peptidyl-prolyl cis/trans isomerases
(PPIases) function in conjunction with posttranslational modifi-
cations on spliceosome components to direct these remodeling
events.
Major Enzymatic Driving Forces for Spliceosome
Remodeling
DExD/H-type RNA-dependent ATPases/helicases that were
discovered early on by elegant yeast genetic studies constitute
one group of proteins that carry out the remodeling of the
spliceosome interaction network. Eight of these DExD/H-box
proteins (Sub2/UAP56, Prp5, U5-100K/Prp28, Brr2/U5-200K,
Prp2, Prp16, Prp22, and Prp43) are conserved between yeast
and humans. They act at specific steps of splicing (Staley and
Guthrie, 1998) (Figure 2B) to facilitate transitions between mutu-
ally exclusive RNA-RNP interaction networks. By removing inter-
action partners (RNA or proteins), these proteins may allow
a particular region of RNA to engage in new base pairing or
protein binding (Pyle, 2008; Staley and Guthrie, 1998).
Sub2/UAP56 and Prp5 act during early spliceosome assembly
stages, where they facilitate the exchange of SF1 for the U2
snRNP at the BPS. The transition from the B to the B* complex,
where catalytic activation of the spliceosome takes place,
requires the action of three additional DExD/H-box proteins as
well as the GTPase, Snu114. The Prp28 protein is involved in
mediating the transfer of the 50SS from the 50 end of the U1
snRNA to the ACAGAG motif in U6 snRNA (Figure 4C). This event
initiates the catalytic activation of the spliceosome. Brr2 is
subsequently required for the unwinding of the U4/U6 duplex
(essentially unpacking part of the ‘‘cutting tool’’) and to allow
annealing of U6 with U2. The activities of Prp28 and Brr2 must
be coordinated, and Brr2 must be tightly regulated to preventet al., 2007). These observations, in particular the findings in
yeast where alternative splicing is extremely rare, suggest that
pre-mRNA substrates differ even in their requirements for core
components of the spliceosome. This may be due to different
affinities between components of the spliceosome and the
various pre-mRNAs or the redundant nature of splicing signals.
Thus, the large compositional complexity of the spliceosome is
likely due at least in part to the wide variety of pre-mRNA
substrates it must engage and the widespread occurrence of
regulated splicing events, at least in higher eukaryotes.
Extensive Remodeling of Spliceosomal Subunits
In contrast to the ribosomal subunits, spliceosomal subunits, in
particular the U4/U6.U5 tri-snRNP, undergo massive remodeling
during splicing. At the time of tri-snRNP interaction with the pre-
mRNA, the U4/U6 and U5 snRNPs are stably associated with
each other, predominantly through a number of protein-protein
interactions (Figure 6A). The U4 and U6 snRNAs are extensively
base paired with each other. The U4 snRNA is associated with
the 15.5K/Snu13 protein and four other proteins (Liu et al.,
2007; Nottrott et al., 1999), whereas the U6 snRNA is bound at
its 30 end by the LSm 2–8 proteins (Achsel et al., 1999; Mayes
et al., 1999). Upon catalytic activation, the U4/U6 base-pairing
interaction is disrupted, freeing the U6 snRNA to engage the
pre-mRNA and U2 snRNA. The U4 snRNA and all U4/U6-associ-
ated proteins are destabilized or released from the spliceosome,
along with proteins involved in tethering the U5 snRNP to the U4/
U6 snRNP (Figure 6A). Whether these proteins are destabilized
or released concomitantly or in discrete steps is not yet clear.
In general, there is little known about how many discrete RNP
remodeling events and thus how many structurally distinct spli-
ceosome intermediates exist during splicing. Indeed, each rear-
rangement represents a step at which splicing can potentially be
subjected to regulation. As the U6 snRNA has been ‘‘stripped’’ of
all of its precatalytic binding partners, new partners must be
provided. Anchoring of the U6 snRNA after activation likely
involves the pre-mRNA substrate, U2 snRNA, and new protein
interaction partners (Figure 6A). Yeast NTC complex (Prp19/
CDC5 complex in metazoans) subunits and Prp19-related
proteins clearly play an important role in this process, as has
been demonstrated in yeast (Chan et al., 2003). It will be inter-
esting for future studies to determine which of these proteins
directly contacts the U6 snRNA at this stage.
Several U5 proteins are also released during the B complex to
C complex transition (Figure 6B). Comparative proteomic anal-
yses have been performed on spliceosomal complexes and
a new 35S form of the U5 snRNP that was purified from HeLa
nuclear extract under stringent conditions. These studies indi-
cated that during spliceosome activation, Prp19/CDC5 complex
subunits and Prp19-related proteins stably associate with the U5
snRNP (Makarov et al., 2002). The remodeled 35S form of the U5
snRNP probably represents a disassembly intermediate of the
post-spliceosomal complex. Whether it initially dissociates as
part of a larger complex containing U6, for example, is presently
not clear as relatively little is known in detail about the
dissociation phase of the spliceosome. In a later step, the 35S
U5 snRNP must be converted back into a 20S form that reasso-
ciates with the U4/U6 snRNP prior to the next round of splicing
Figure 6. The U4/U6.U5 tri-snRNP Is Extensively Remodeled during Splicing
(A) Disruption of U4/U6 base-pairing interactions and loss of all U4/U6 proteins, as well as some U5 and tri-snRNP proteins, during catalytic activation of the
spliceosome. The regions of U4, U6, and U2 snRNAs that engage in new base-pairing interactions after spliceosome activation are highlighted in yellow or
red. Only the 50 end of U2 and the 50 end of the pre-mRNA (exons, blue box; intron, black line) are depicted. After the loss of all known precatalytic U6
snRNA-binding partners, additional proteins (pink) that include the subunits of the nineteen complex (NTC) in yeast (Chan et al., 2003) and the Prp19/CDC5
complex and Prp19-related proteins in humans help to tether the U6 snRNA to the activated spliceosome. Proteins are depicted in relative size to each other
and are denoted by yeast nomenclature except for the human 27K protein, which has no yeast homolog.
(B) Remodeling of the U5 snRNP (red) during the splicing cycle, as proposed by Makarov et al. (2002). During activation, the U5 snRNP appears to be remodeled
so that it interacts stably with the Prp19/CDC5 complex and Prp19-related proteins. U5 is thought to dissociate after splicing in the form of a 35S particle and must
then be converted to a 20S form before it can associate with the U4/U6 snRNP and partake in another round of splicing. The size of the U5 snRNP reflects its
compositional complexity at various stages of the splicing process.A number of very recent findings suggest that Prp8, the largest
and most highly conserved protein of the spliceosome (Grainger
and Beggs, 2005), may provide much of this regulation for Brr2. A
fragment in the C-terminal quarter of the protein was shown
to adopt an RNase H-like fold that is augmented by otherpremature cleavage of the pre-mRNA. Furthermore, Brr2 is
a resident subunit of the spliceosome and its activity is required
again during spliceosome disassembly (Small et al., 2006). Thus,
it requires a control mechanism that can be switched on and off
repeatedly.Cell 136, 701–718, February 20, 2009 ª2009 Elsevier Inc. 711
Prp8-specific elements (Pena et al., 2008; Ritchie et al., 2008;
Yang et al., 2008). The nature of many genetic and physical inter-
actions (reviewed in Grainger and Beggs, 2005) that map to this
RNase H-like domain in Prp8 suggest that it acts together with
Prp28 to provide a trans-helicase activity for the robust handover
of the 50SS from U1 to U6 (Pena et al., 2008) (Figure 4B). The
RNase H domain in Prp8 is followed by an expanded Jab1/
MPN domain that extends to the C-terminal end of the protein
(Pena et al., 2007; Zhang et al., 2007). Strikingly, a C-terminal
fragment of Prp8 comprising the RNase H and Jab1/MPN
domains interacts with Brr2 and stimulates its helicase activity
(Maeder et al., 2009). Thus, a platform within Prp8 appears to
organize the activities of both Prp28 and Brr2 (Figure 4C).
Additional levels of regulation are also present to tightly control
the activity of Brr2. In yeast, Prp8 is reversibly ubiquitinylated and
its ubiquitinylated form represses Brr2 activity (Bellare et al.,
2008). The Jab1/MPN domain of Prp8 binds ubiquitin (Bellare
et al., 2006), suggesting that upon deubiquitinylation of Prp8,
this domain could be liberated to stimulate Brr2 activity. Further-
more, Brr2 is under the control of the Snu114 GTPase (Bartels
et al., 2002; Small et al., 2006). GDP-bound Snu114 blocks
Brr20s helicase activity, whereas its GTP-bound form promotes
helicase activity (Small et al., 2006). Interestingly, Snu114 inter-
acts with the same region of Prp8 as Brr2 (Liu et al., 2006;
Pena et al., 2007; Zhang et al., 2007) (Figure 4C). Therefore,
the C-terminal region of Prp8 may additionally coordinate
Snu114 control of Brr2, thus representing a hot spot for the regu-
lation of spliceosome catalytic activation. Moreover, Prp8, Brr2,
and Snu114 form a salt-stable complex that can be detached
from the U5 snRNP (Achsel et al., 1998), suggesting that these
proteins are organized as a functional unit or a micro-machine
within the spliceosome.
Another safeguard against ill-timed pre-mRNA cleavage may
be provided by Prp2, the least understood helicase of the spli-
ceosome. Prp2 activity is required after U4/U6 unwinding by
Brr2 and before the first step of the splicing reaction (Kim and
Lin, 1996). It may also control yet another rearrangement that
changes an activated spliceosome (characterized by the
removal of U1 and U4) to a particle that is catalytically competent
for the first transesterification step (Figure 2B). Prp16, Prp22, and
Prp43 also facilitate structural changes in the spliceosome
during later stages of splicing. Prp16 (Schwer and Guthrie,
1992) and Prp22 (Schwer, 2008) act prior to and during the
second transesterification step, respectively, whereas Prp43
(Arenas and Abelson, 1997) functions during spliceosome disas-
sembly (Figure 2B).
Most of the spliceosomal helicases seem to be geared toward
the local reorganization of RNA-RNA or RNA-protein interac-
tions, reminiscent of canonical DEAD-box proteins (Sengoku
et al., 2006). Several of these enzymes, including Prp5 (Xu and
Query, 2007), Prp16 (Burgess et al., 1990), and Prp22 (Mayas
et al., 2006), also act as timers for kinetic proofreading to ensure
accuracy in the splicing process. These factors mediate swift
transitions along the splicing pathway if a suitable substrate is
presented and allow disposal of suboptimal substrates that are
not rapidly converted. The activities of such enzymes have there-
fore been likened to the role played by the elongation factor
eEF1A/EF-Tu during translation (Burgess et al., 1990). The712 Cell 136, 701–718, February 20, 2009 ª2009 Elsevier Inc.recent observation that spliceosomes can reverse both transes-
terification reactions (Tseng and Cheng, 2008) suggests that
additional possibilities for proofreading may exist.
Regulation of the DExD/H-box enzymes is not very well under-
stood. Most of the RNA helicases join the spliceosome tran-
siently at the stage at which their actions are required
(Figure 2B), comparable to the association of elongation factors
with the ribosome during translation elongation. Similar to the
elongation factors, some of these helicases may exhibit overlap-
ping binding sites, thereby explaining in part their sequential
recruitment. In addition, specific protein partners may mediate
recruitment of a helicase (for example, Spp2 in the case of
Prp2; Roy et al., 1995) or modulate its activity (for example,
Ntr1 in the case of Prp43; Tsai et al., 2005).
Although the above DExD/H-box proteins are evolutionarily
conserved, demonstrating the conserved nature of the remodel-
ing events they facilitate, at least four other DExD/H-box proteins
without obvious counterparts in yeast are found in human spli-
ceosomes (p68, KIAA0560, Abstrakt, DDX35). Thus far, a func-
tional role has only been ascribed to p68, which appears to act
during catalytic activation (Liu, 2002). It remains to be deter-
mined whether the remaining three proteins are also involved
in additional remodeling steps that may be specific to the human
spliceosome.
Additional Enzymatic Driving Forces?
Additional proteins associated with the spliceosome also
possess enzymatic activities that could modulate protein confor-
mations and thereby steer spliceosome assembly and catalysis.
Human spliceosomes contain at least eight peptidyl-prolyl cis/
trans isomerases (PPIases) that are recruited at distinct stages
during splicing. The precise functions of the spliceosomal
PPIases, all of which are members of the cyclophilin family,
remain to be established. As most of these proteins have no
obvious orthologs in yeast where there is little occurrence of
alternative splicing, these PPIases might function specifically in
higher eukaryotes to enhance the flexibility of the spliceosome
during processes such as alternative splicing. The isomerization
of a peptide bond preceding a proline residue can be the rate-
determining step in protein folding (reviewed in Nagradova,
2007). Thus, spliceosomal PPIases may mediate structural tran-
sitions that otherwise might slow down pre-mRNA splicing. This
is consistent with the observation that the cyclophilin inhibitor,
cyclosporin A, affects both steps of the splicing reaction (Horo-
witz et al., 2002). Also consistent with a remodeling function for
these proteins, at least some of these PPIases appear to asso-
ciate with the spliceosome in a way that leaves their PPIase
active sites unobstructed. For example, the PPIase cyclophilin
H (CypH) associates with the U4/U6-Prp4 complex through
a region that is located opposite its active site (Reidt et al.,
2003). Many other spliceosomal PPIases also appear to harbor
additional domains for mediating spliceosome association that
are distinct from those containing their active sites. These
include an RNA recognition motif in CypE, a WD40 domain in
Cyp64, and an RS domain in PPIase G (PPIG).
The above enzymes are potentially involved in at least one
protein conformational switching event during splicing. Consid-
ering that Brr2, Snu114 (Small et al., 2006), and Prp22 (Mayas



























-N-terminal region also associates with several other spliceoso-
mal proteins such as U2AF65 (Figure 3), SPF45, and PUF60,
which may similarly induce structural changes in this region of
SF3b155.
SF3b155 further provides an example of how posttranslational
modifications can lead to structural transitions in modified intrin-
sically unstructured proteins or regions to provide new interac-
tion platforms. The NIPP1 protein, which contains a phospho-
threonine/serine-binding forkhead-associated domain, interacts
with SF3b155 in a manner that depends upon the phosphoryla-
tion of specific threonine-proline motifs in the unstructured
SF3b155 N-terminal region (Boudrez et al., 2002). Furthermore,
NIPP1 appears to communicate the SF3b155 phosphorylation
state to protein phosphatase-1 (Tanuma et al., 2008). Interest-
ingly, the juxtapositioning of prolines with phosphorylated amino
acids in SF3b155 is reminiscent of the C-terminal domain of the
largest RNA polymerase II subunit. There, phosphorylation
marks, whose configurations are further modulated by the
PPIase PIN1, constitute an intricate code for the recruitment of
mRNA processing factors (reviewed in Lu and Zhou, 2007). It
will be interesting to see whether similar strategies involving
the spliceosomal PPIases are implemented in the spliceosome.
Other distinguishing aspects of intrinsically unstructured
proteins or regions include their conformational malleability,
which allows them to contact diverse interaction partners, and
their immobilization or folding upon complex formation, which
enables the formation of specific complexes with limited thermo-
dynamic stability. Intrinsically unstructured proteins or regions
also are able to accelerate interaction kinetics by allowing
a greater radius of target binding site capture (fly-casting mech-
anisms) and are readily inactivated through protein degradation.
These attributes make the intrinsically unstructured proteins or
regions appear ideally suited to promote the extraordinary plas-
ticity of the spliceosome. Therefore, we expect that they likely
play a central role in maintaining the dynamic nature of the
splicing machinery.
Regulatory Decisions of the Spliceosome
Several of the design principles of the spliceosome, including its
extensive compositional dynamics and its flexible intermolecular
RNA-RNA, RNA-protein, and protein-protein interactions,
ensure that it is highly responsive to regulation. These character-
istics are in part a consequence of its assembly from a large
number of smaller subunits. Many alternative splice-site choices
are made during the very early phases of spliceosome
assembly. As previously discussed, these choices are deter-
mined by the combined actions of both positive and negative
regulatory proteins and the contribution of splicing enhancer
and silencer sequences (reviewed in Smith and Valcarcel,
2000). Recent results indicate that regulatory decisions are
also made at later stages of the splicing process, including
during the transition from a cross-exon A-like complex to
a cross-intron B complex (Bonnal et al., 2008; House and Lynch,
2006; Sharma et al., 2008) and even after the first step of splicing
(Lallena et al., 2002). Furthermore, recent data have unexpect-
edly revealed that the spliceosome mediates the maturation of
the 30 end of telomerase RNA (the catalytic subunit of the telo-
merase RNP enzyme) by cleaving the RNA from a longer(Figure 2B), a number of these proteins may also have more than
one function. Snu114 also exhibits striking sequence homolog
with the ribosomal translocase eEF2/EF-G (Fabrizio et al.
1997). Though this similarity suggests that Snu114 may function
like a motor protein and facilitate mechanical movements during
spliceosome assembly or catalysis, more recent data indicate
that Snu114 acts more like a molecular switch, transducing
signals to Brr2 (Small et al., 2006). Nonetheless, more spliceo
some maturation states than the limited number identified to
date must exist.
Molecular Switches during Spliceosome Assembly
and Catalytic Activation
Several spliceosomal proteins are posttranslationally modified
Many of these modifications play key regulatory roles in the
progression of splicing. The spliceosome harbors a number o
enzymes that introduce or remove posttranslational modifica
tions. At least four protein kinases (SR protein kinases 1 and 2
Prp4 kinase, and Clk/Sty kinase) have been shown to phosphor
ylate spliceosomal proteins. Reversible protein phosphorylation
of spliceosomal proteins plays decisive roles during both spli
ceosome assembly and splicing catalysis (Mathew et al., 2008
Shi et al., 2006 and references therein). For instance, the phos
phorylation of SR proteins is essential for their activity. Phos
phorylation of Prp28, a component of the U5 snRNP, is required
for tri-snRNP addition during spliceosomal B complex formation
(Mathew et al., 2008). The U1 snRNP-associated 70K protein i
also a phosphoprotein and its dephosphorylation is required
for the first step of splicing. Finally, the U2-associated
SF3b155 protein is specifically hyperphosphorylated just prio
to or during the first step of splicing (Wang et al., 1998) and
appears to be dephosphorylated by PP1/PP2A phosphatase
concomitant with the second step of splicing (Shi et al., 2006)
Spliceosomal proteins also appear to undergo other types o
modifications. These include ubiquitination, as in the case o
Prp8 (Bellare et al., 2008), and possibly also acetylation (Kuhn
et al., 2009). More detailed characterization of the modification
status of spliceosomal proteins using mass spectrometry wi
likely greatly expand our knowledge of the number and nature
of modified proteins. These analyses are likely to revea
a plethora of molecular switches that contribute to the fine tuning
of the splicing process and provide additional opportunities fo
regulation.
Traditionally, the functions of biological macromolecules are
thought to intimately depend on stable structures, as is the
case for most RNP machines. However, a large number o
proteins that are either natively disordered (intrinsically unstruc
tured proteins, IUPs) or bear sizeable regions that lack stable
tertiary structure (intrinsically unstructured regions, IURs) do
not follow this structure-function paradigm (reviewed in Dyson
and Wright, 2005). A well-studied example of such proteins in
the spliceosome is SF3b155. This protein exhibits a C-termina
array of 22 tandem helical repeats that form a major scaffolding
element for the heteromeric SF3b complex (Golas et al., 2003)
However, the N-terminal 450 amino acid region of SF3b155 i
intrinsically unstructured (Cass and Berglund, 2006). Binding o
the SF3b14a/p14 protein to the end of the unstructured
N-terminal region induces a folding transition in SF3b155 (Schel
lenberg et al., 2006; Spadaccini et al., 2006). The SF3b155Cell 136, 701–718, February 20, 2009 ª2009 Elsevier Inc. 713
precursor through a reaction identical to the first catalytic step of
splicing (Box et al., 2008). However, the spliceosome does not
perform the second step of splicing on the telomerase RNA,
indicating that its activity in this context is negatively regulated
after the first catalytic step. Indeed, there are likely to be a multi-
tude of checkpoints throughout the splicing cycle where the spli-
ceosome can make decisions that alter the outcome of the
splicing process.
The Spliceosome’s Active Site
The spliceosome qualifies as an RNP enzyme due to the exten-
sive interplay of RNA and protein functions during assembly and
catalytic activation. Yet, the question remains whether coopera-
tion between RNA and protein extends to the chemical catalysis
of splicing. The chemistry of nuclear pre-mRNA splicing recapit-
ulates the self-splicing that is catalyzed by group II introns.
Furthermore, the short sequences of some snRNAs that
resemble catalytic portions of group II introns. Analysis of the
effects of thioester substitutions in the pre-mRNA has estab-
lished that the spliceosome is a metalloenzyme (Sontheimer
et al., 1997). Phosphorothioate-suppression experiments further
demonstrated that the U6 intramolecular stem loop mediates the
positioning of a catalytically or structurally important metal ion
(Yean et al., 2000). Intriguingly, the recent crystal structure of
a hydrolytic group IIC intron revealed that its U6-like intramolec-
ular stem loop might mediate the transesterification reactions by
coordinating two metal ions for catalysis (two-metal-ion mecha-
nism) (Toor et al., 2008). Furthermore, engineered RNAs that
contain only portions of U6, U2, and the pre-mRNA can carry
out a reaction resembling the first step of splicing (Valadkhan
and Manley, 2001). However, it remains unclear to what extent
this minimal system represents the situation in the spliceosome.
Taken together, these findings leave no doubt that snRNAs and
the pre-mRNA form major parts of the spliceosome’s active sites.
However, it is presently still unclear whether group II introns and
the spliceosome represent divergent or convergent evolutionary
solutions to the same chemical problem and whether they share
the same chemical catalytic principles (Weiner, 1993).
Biochemical and genetics analyses place at least two spliceo-
somal proteins directly at or near the spliceosome’s active sites.
One of these proteins is the U2-specific SF3b14a/p14 protein,
which contacts the BPS adenosine during the early stages of
spliceosome formation and also after the first catalytic step
(Will et al., 2001). The other protein is the U5-specific Prp8
protein, which can be crosslinked to the 50SS, the BPS, and
the 30SS after association of the U5 snRNP during B complex
formation. Prp8/U5-220K has also been suggested to function
as a scaffold for active site RNAs or proteins (reviewed in
Grainger and Beggs, 2005). Recent crystal structures of
a 50SS-interacting region of Prp8 revealed an RNase H-like
domain containing a truncated catalytic center (Pena et al.,
2008; Ritchie et al., 2008; Yang et al., 2008). Together with the
effects of single point mutants targeting both the apparent active
site residues of the RNase H-like domain and the surrounding
area in Prp8 (Pena et al., 2008; Ritchie et al., 2008; Yang et al.,
2008), these results point to the possibility that Prp8 may directly
participate in the chemical catalysis of splicing and that the
active sites of the spliceosome may be true collaborations
between RNA and protein (Abelson, 2008).714 Cell 136, 701–718, February 20, 2009 ª2009 Elsevier Inc.Toward Monitoring Dynamic RNPs in Action
A full mechanistic understanding of an RNP machine requires
structural information about each of its numerous functional
stages, as has been demonstrated impressively with the ribo-
some (reviewed in Korostelev et al., 2008; Steitz, 2008). The
most fundamental requirement to attain comparable structural
knowledge for the spliceosome is the availability of homoge-
neous preparations of the RNP particle in defined functional
stages. Presently, the most successful techniques of spliceo-
some isolation combine kinetic control of spliceosome assembly
with affinity purification steps and glycerol gradient centrifuga-
tion (Bessonov et al., 2008 and references therein). The resulting
preparations are amenable to structural investigation, including
mapping of specific spliceosomal components by cryo-electron
microscopy (reviewed in Stark and Lu¨hrmann, 2006). However,
these preparations will probably require greater homogeneity
for high-resolution studies.
The control of particle homogeneity may be aided by small-
molecule inhibitors that stall the splicing machinery at specific
steps. This approach has been particularly successful in the
study of the ribosome, for which nature has provided a large
number of antibiotics that allow stalling of this RNP at different
functional stages. No comparable natural inhibitors of pre-
mRNA splicing are known. Because spliceosomal enzymes
embody the driving forces for spliceosome assembly and
remodeling, inhibitors that specifically block the activities of indi-
vidual enzymes should be useful for stalling the spliceosome at
specific stages. Indeed, recent screening efforts have unearthed
a number of chemicals that block pre-mRNA splicing at different
stages in vitro (reviewed in Jurica, 2008). In the future, it will be of
primary importance to test whether these substances can
generate more homogeneous spliceosome preparations that
are amenable to high-resolution ultrastructural analyses.
However, reconstitution of spliceosomal complexes at defined
stages using purified subcomplexes and recombinant proteins
may ultimately be required to achieve this goal. Because of the
apparent lower number of spliceosome-associated proteins in
yeast and also the availability of yeast spliceosomal proteins
harboring temperature-sensitive mutations, the yeast system
may prove particularly useful for determining, at high resolution,
the molecular structure of the spliceosome.
Due to the ease with which the structural context of RNA mole-
cules can be probed biochemically, we possess a relatively
detailed picture of RNA transactions during pre-mRNA splicing.
In contrast, little is known about the structural rearrangements
that involve spliceosomal proteins because no comparable
protein footprinting techniques are available. Hydrogen-deute-
rium exchange monitored by mass spectrometry (Maier and
Deinzer, 2005) has proven useful for delineating molecular
surfaces that are buried upon complex formation or during
a folding transition. Moreover, radiolytic footprinting in combina-
tion with mass spectrometry constitutes a promising approach
to revealing dynamic interaction networks in protein complexes
(Takamoto and Chance, 2006).
Site-specific labeling of individual subunits with spectroscopic
or biochemical probes and reconstitution of functional
complexes bearing such reporter groups would be tremen-
dously useful to allow tracking of the changing molecular
the 30- end of U6 snRNA, thereby facilitating U4/U6 duplex formation in vitro.
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include the introduction of fluorescent probes for fluorescence
resonance energy transfer measurements or for tracking the
dynamics of RNA/RNP remodeling events using single-molecule
approaches. They also include the introduction of hydroxyl-
radical generators that allow mapping of RNAs in the vicinity of
the probe. Pioneering work was again carried out in the study
of ribosomes (reviewed in Wilson and Noller, 1998), and first
steps in this direction have been undertaken with the spliceo-
some (Crawford et al., 2008; Donmez et al., 2007; Rhode et al.,
2006; Kent and MacMillan, 2002).
In order to decipher the combinatorial control involved in
splice-site selection and pairing, as well as the principles under-
lying the cooperative activities of multiple splicing regulatory
proteins, thermodynamic and kinetic parameters that describe
their molecular interactions are required. Again, studies of the
ribosome teach us that every step must be described kinetically
in order to achieve a full mechanistic understanding (Winter-
meyer et al., 2004). Surprising results may lie ahead with the
attainment of a more detailed kinetic description of spliceosome
assembly. Indeed, Nilsen and colleagues have recently charac-
terized a new type of exonic splicing silencer that modulates
the kinetics with which a U1 snRNP-bound 50SS engages in
splicing (Yu et al., 2008). Interestingly, these new regulatory
sequences did not appear to require binding by auxiliary splicing
factors.
Many approaches discussed here, as well as classical
biochemical techniques such as crosslinking approaches,
should provide useful information regarding the spatial relation-
ship of components within the spliceosome at different stages of
the splicing cycle. These disparate pieces of data would provide
spatial constraints for integrative modeling techniques to
generate congruent three-dimensional pictures of the splicing
machinery, as has recently been pioneered with the nuclear
pore complex (reviewed in Alber et al., 2008). With this arsenal
of techniques, it may prove possible to unravel the conforma-
tional and compositional dynamics of the spliceosome over the
course of the splicing cycle at near-atomic resolution.
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